- From confidence to capital: Positioning biotech for the next growth cycle<p>How can biotechs be investor ready? Key takeaways from BIO International and DIA China 2026.</p>BioPharma Dive · 2h ago↗ source
- Denmark’s foundation‑fueled biotech boom redraws the Nordic mapInvestment and a maturing talent base have propelled Denmark ahead of its Nordic peers, drawing Swedish companies and exposing regional gaps in capital and scale.BioSpace · 4h ago↗ source
- Argenx acquires Forte for $2.2B to get hands on phase 2-stage vitiligo drugArgenx is spending $2.2 billion to absorb Forte Biosciences for its phase 2-stage vitiligo and celiac disease drug.Fierce Biotech · 5h ago↗ source